Sonostics Inc. was formed in 2008 to commercialize innovative biotechnology developed at Binghamton University. In 2013, the company re-focused its efforts on non-invasively, non-pharmacologically alleviating symptoms associated with poor circulation and reduced venous return to the heart which allows fluid to pool in the lower body. The basic research in this area was undertaken by Dr. Kenneth McLeod and his team in the Clinical Science and Engineering Research Center at Binghamton University. This work resulted in the creation of the HeartPartner. HeartPartner employs proprietary technology to non-invasively enhance the performance of the Soleus muscles, also known as “the secondary hearts” of the human body. Secondary Heart activation improves circulation, and alleviates symptoms associated with lower limb fluid pooling such as unexplained fatigue, dizziness, blurred vision, cognitive dysfunction, as well as swelling of the legs and feet, and varicose veins, among others.
Meet the team
Dr. Ken McLeod
VP of Sales & Marketing
In the News
wicz.com - 1/14/17
A normal week at Sonostics means selling about 10 HeartPartners. But since the beginning of January, the company has sold 86 devices, exceeding its sales goals for the first quarter of the year.
"It's going to be little successes. Small start-up companies, technology companies,
medical device packaging, nanotechnology companies and industries related to electronics
and packaging, that's the wave of the future I believe," said Washington.
Developed by Sonostics, a BU-developed company through STARTUP-NY, the Heart Partner stimulates the nerves at the bottom of each foot while a person sits, exercising the muscle. When the calf muscle is idle, it starts to deteriorate, and there is correlation between the weak muscle and dementia/declining cognitive functions, along with unexplained fatigue, dizziness, swelling in the legs or ankles, difficulty concentrating and cold hands and feet.